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ollagen, a major matrix protein of skin, bone, tendon,
and other tissues, is the most abundant protein in all
mammals. It is composed of a heterotrimer contain-
ing two a1(I) and one a2(I) chains with over 1000
residues each. Type I collagen has 338 triplet repeat-
ing units of Gly-X-Y within each chain where Gly is placed at
every third position as required for the formation of the tight
helix and the close packing of the three chains. In vertebrate
collagens, proline and 4-hydroxyproline (Hyp) are most fre-
quently found at positions X and Y, respectively. A high con-
tent of Pro and Hyp is necessary for stabilizing the extended
polyproline II-like helices. The helical domain is capable of
self-association to form fibrils and is used for binding to
integrins, proteoglycans, matrix metalloproteinases, and so
on.1,2 In this helical domain there are sequence variations to
specify binding sites and regions for local microunfolding
and forming cooperative folding units.3,4
Mutation of collagen leads to heritable connective tissue
disorders, such as osteogenesis imperfecta (OI),5 which is
characterized by a defective skeletal matrix and susceptibility
to fractures.6–8 The most common cause of OI is single point
mutation from Gly to another residue such as Cys, Ser, Ala,
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ABSTRACT:
Molecular dynamics simulations were carried out to
calculate the free energy change difference of two
collagen-like peptide models for Gly?Ser mutations
causing two different osteogenesis imperfecta phenotypes.
These simulations were performed to investigate the
impact of local amino acid sequence environment
adjacent to a mutation site on the stability of the
collagen. The average free energy differences for a
Gly?Ser mutant relative to a wild type are 3.4 kcal/mol
and 8.2 kcal/mol for a nonlethal site and a lethal site,
respectively. The free energy change differences of mutant
containing two Ser residues relative to the wild type at
the nonlethal and lethal mutation sites are 4.6 and 9.8
kcal/mol, respectively. Although electrostatic interactions
stabilize mutants containing one or two Ser residues at
both mutation sites, van der Waals interactions are of
sufficient magnitude to cause a net destabilization. The
presence of Gln and Arg near the mutation site, which
contain large and polar side chains, provide more
destabilization than amino acids containing small and
nonpolar side chains. # 2011 Wiley Periodicals, Inc.
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Arg, Val, Glu and Asp. These mutations occur over the full
range of the a1(I) and a2(I) chains of collagen and result in
clinical phenotypes ranging from perinatal lethal to mild.9
Important factors for the severity of OI include the type of
a1(I) and a2(I) chains, the nature of amino acids substituted
for Gly, amino acid sequence environment adjacent to a
mutation site, position of the mutation with respect to C-ter-
minus, and level of expression of mutant allele.9–11 The effect
of amino acid sequence is the subject of this study.
According to statistical analysis of the severity of OI, sub-
stitution of Asp for Gly is consistently lethal. Arg, Val, and
Glu are lethal unless the mutation sites are near the N-termi-
nus.12 This observation indicates the C- to N-terminal fold-
ing direction of the collagen triple-helix;13 however, the se-
verity of phenotype for the mutation from Gly to Ala, Cys,
and Ser does not follow this trend in a1(I) and a2(I)
chains.12 These amino acids show various phenotypes all
along the chains and the clinical phenotypes of Gly?Cys
and Gly?Ser mutations are determined by amino acid
sequence environment adjacent to a mutation site.11,14,15
Our previous stochastic boundary molecular dynamics
(SBMD) simulations of collagen model peptides of [Ac-(Gly-
Pro-Hyp)9-NH2]3 were performed to calculate free energy
change differences of mutants containing an Asp, a Cys, a
Glu or a Ser residue relative to the wild type, which correlates
with the clinical severity of OI from statistical analysis.16 As
expected based on the statistical analysis of OI, the free
energy change differences of mutants bearing a Cys or a Ser
residue relative to the wild type are smaller than those of the
mutants containing a Glu and an Asp residue; however, the
clinical phenotypes of the Gly?Cys and Gly?Ser mutations
can be changed by the amino acid sequence environment ad-
jacent to a mutation site.11,14,15 One of the remarkable
instances showing different phenotypes for the Gly?Ser
mutation is found in human collagen at positions 901 and
913. In this case, nonlethal (901) and lethal (913) phenotypes
are observed even when the type of mutation is the same and
the two mutation sites are in close proximity.17,18
Homotrimeric triple helical collagen model peptides con-
taining the nonlethal (901) and lethal (913) mutation sites
for Gly?Ser mutation were synthesized to study the stability
and folding of the peptides.19 It was found that the Gly?Ser
mutation at site 913 caused a significant decrease in thermal
stability of the mutant relative to the wild type at site 901.19
Although of interest, this study is limited by the nature of the
homotrimeric peptide and the non-native addition of the
four repeating units of Gly-Pro-Hyp at the C-terminus of
the peptides. Furthermore, one amino acid mutation of the
model peptide leads to mutation of three amino acids of the
triple helix model because the peptides are homotrimeric.
These experimental limitations can be overcome by a compu-
tational study on the triplet helical system because the het-
erotrimeric peptide systems can be easily built in silico.
Mutations of one or two residues can be carried out to study
the stability of the heterozygous and homozygous mutants
relative to the wild type. Moreover, decomposition of the
total free energy into each contribution from the potential
energy function provides detailed analysis of the effect of
mutations on the thermal stability of the system.
Herein we have performed SBMD simulations to calculate
free energy change differences caused by the amino acid
sequence environment surrounding the Gly?Ser mutation
(see Figure 1). Two 30-residue heterotrimeric peptides contain-
ing a mutation site were built based on a human collagen
sequence and a previously reported crystal structure of colla-
gen-like peptide.20 The peptides were prepared to include local
regions of the a1(I) chain bearing mutation sites of the nonle-
thal Gly?Ser mutation at position 90117 and the lethal
Gly?Ser mutation at position 913.18 We utilized standard
free-energy simulation with thermodynamic integration and a
coupling parameter approach to estimate free energy changes
for each peptide system at the folded and unfolded states.
Our goal is to provide a microscopic understanding of the
effect of amino acid sequence environment adjacent to a
mutation site on their thermal stability of heterozygous and
homozygous mutant collagens. These calculated results pro-
vide a better understanding of the details of free energy dif-
ferences of the collagens caused by the single point mutation.
The calculated free energy change differences of nonlethal
and lethal mutants relative to the wild type are compared to
the severity of OI mutants obtained from statistical analysis.
These free energy change differences are also expected to
agree with the trend in the previous free energy change dif-
ferences from the simulations of the collagen models of
[(Gly-Pro-Hyp)10]3 for the mutations from Gly to Cys, Ser,
Glu, and Asp.16 The simulation method can be used to pre-
dict the severity of unknown mutations in OI and collagen-
related diseases caused by amino acid sequence environment
adjacent to a mutation site.
METHODS
We carried out MD simulations for the mutation Gly ? Ser at
position 15 of two 30-residue collagen-like peptides for the folded
state and for position 3 of two 5-residue monomeric extended
peptides for the unfolded state. Amino acid sequences of folded
and unfolded states from human collagen were employed. The
30-residue collagen sequences containing a mutation site at posi-
tions 901 and 913 (in bold) were selected for two collagen model
peptide systems (a sequence for a peptide containing a mutation
site at position 901: blue lines and a sequence for the other
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peptide containing a mutation site at position 913: red lines in
Figure 2). A mutation site is positioned at the center of each pep-
tide (position 15) for the folded state because of the structural
integrity of the central part of the peptides. Both peptide systems
for the folded and unfolded states were acetylated at N-terminus
and amidated at C-terminus. The peptide model for the folded
state was built based on the sequence of human collagen and a
crystal structure of a collagen-like peptide of [(Gly-Pro-Hyp)10]3
from the protein data bank (PDB code: 1CGD).20 The structure
and sequence of the collagen model peptides are shown in Figures
1 and 2, respectively.
A TIP3P21 water sphere of 16 Å radius centered at the mutated
residue Gly 15 Ha was overlaid and water molecules overlapping the
collagen-like peptide were deleted. The solvated wild type peptide
systems for each simulation contained the following part of the pep-
tide and water molecules.
FIGURE 1 Collagen model peptides (wild type) containing a mutation site at position 901
solvated with a water sphere at the (A) folded and (B) unfolded states. The mutation site is indi-
cated by G (for glycine).
Gly?Ser mutation at position 901 Gly?Ser mutation at position 913
Folded state
Chain A: a1(I) A11G12P13V14G15P16V17G18A19 A11G12P13Q14G15P16R17G18D19
Chain B: a2(I) P13A14G15A16V17G18P19R20G21 P13Q14G15I16R17G18D19K20G21
Chain C: a1(I) G12P13V14G15P16V17G18A19R20 G12P13Q14G15P16R17G18D19K20
Unfolded state PVGPV PQGPR
Each peptide system was minimized using the adopted basis
Newton-Raphson22 optimization algorithm (1000 steps). The MD
simulations were carried out using the molecular simulation
program CHARMM Version 3522 and the CHARMM2223 all-atom
topology and parameters. All hydrogen atoms were explicitly
included and an atom-based 12.0 Å nonbonded cutoff distance was
used with a switching function between 10.0 and 12.0 Å for van der
Waals terms and a shift function at 12.0 Å for electrostatics in all
energy evaluations. All the simulations on the minimized peptides
were carried out by using the SBMD method.24 The spherical dy-
namics reaction region contains the part of the peptide structure
solvated with a water sphere of a radius of 14 Å centered on the Ha
atom of a mutating residue. In this dynamics region all atoms per-
formed Newtonian dynamics under the CHARMM force field. The
dynamics region was surrounded by a 2-Å buffer region where the
atoms carried out Langevin dynamics with a friction coefficient of
200 ps21.25 Water molecules were restrained to stay within 16 Å of
the system center by a spherical mean-field potential.24
The calculated results (DDGcalc) can be related to the experimen-
tal measurements (Eq. 2) in the thermodynamic cycle in Figure 3.
The thermodynamic cycle for double mutations was setup in the
same way as previously published.16,26 The thermodynamic win-
dowing method was used to calculate free energy changes of the sys-
tem. Thermodynamic properties were estimated using the coupling
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parameter approach25,27–29 employing a hybrid potential energy
function given by U(k) 5 (1 2 k)UGly 1 kUSer 5 UGly 1 kDU,
where UGly corresponds to system with a Gly residue (a wild type),
USer corresponds to the same system with a mutated residue
(mutants) at the same position, and DU 5 USer 2 UGly. The cou-
pling parameter k indicated the progress of the mutation with UGly
for the initial state (k 5 0) and USer for the final state (k 5 1). The
SBMD simulations were performed at five values of k (k 5 0.1, 0.3,
0.5, 0.7, 0.9). The whole system was equilibrated for 200 ps with
k 5 0.1 after the solvent was equilibrated for 100 ps with the pep-
tide constrained. After the equilibration of the system, equilibration
was carried out for 500 ps, followed by production runs for 2 ns at
each k value. The free energy change DG between the initial (k 5 0)
and the final (k 5 1) states was calculated by the thermodynamic
integration method (Eq. 3).25 A thermodynamic cycle was used to
calculate the free energy change differences for 1st and 2nd Gly?Ser
mutations in two collagen model peptides (see Figure 3). The free
energy changes of folded-state model for the first and second Gly
mutations on chain A as well as chain C were calculated because of
different chemical and geometrical environment of mutation sites.
Three simulations for a mutation were carried out using three
different random number generators used for assigning velocities.
The average temperature was 299 K for the simulation at folded and
unfolded states. Two nanosecond of SBMD of the system required
about 24 hr of CPU time on the dual Quad-core Intel Xeon cluster.
Three independent free energy simulations for all the mutations
were carried out to confirm convergence of the simulations. The
resulting statistical errors of the free energy difference changes for







vuut ; xAve: mean values
For each mutation, the estimated free energy changes obtained from
the separate three independent trajectories agree within their statistical
errors. This indicates that the free energy simulation results are converged.
RESULTS
The partially solvated collagen model peptides at the folded
(a) and unfolded states (b) are shown in Figure 1. Free
energy change differences (DDG) and free energy changes
(DG) for the 1st and 2nd Gly?Ser mutations in chains A
and C at positions 901 and 913 are shown in Table I. Because
the central Gly’s on chains A and C have different chemical
and geometrical environments, the mutations were carried
out in two manners: (1) the 1st Gly mutation was carried out
on chain A and the 2nd mutation on chain C (A:C) and (2)
the 1st Gly mutation on chain C and the 2nd mutation on
chain A (C:A). The first and second mutations were carried
out to understand the relative stability of heterozygous and
homozygous mutants with respect to the wild type, respec-
tively. The free energy change differences (DDGTotal) for
Gly?Ser mutations indicate that the wild type is more stable
FIGURE 2 Sequence of the collagen-like peptides. (a) Amino acid sequence of human colla-
gen from residue 887 to residue 928. (b) A 30-residue folded peptide from sequence of human
collagen containing a mutation site at position 901: a1(I)2a2(I). (c) A 30-residue folded peptide
from sequence of human collagen containing a mutation site at position 913: a1(I)2a2(I).
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than the mutants containing two Ser residues at positions
901 and 913 by 4.6 and 9.8 kcal/mol, respectively. The free
energy change differences (DDGTotal) also demonstrate
that the wild type is more stable than the mutant containing
one Ser at positions 901 and 913 by an average 3.4 and
8.4 kcal/mol, respectively. The free energy change differences
of the homozygous and heterozygous mutants at position
901 relative to the wild type are smaller than those of the cor-
responding mutants at position 913 by 4.8 and 5.0 kcal/mol,
respectively. The average value of the free energy difference of
the heterozygous mutants with a Ser at position 901 relative
to the wild type is smaller than that of the heterozygous mu-
tant at position 913 by 4.8 kcal/mol. These energy differences
indicate that both homozygous and heterozygous mutants at
position 901 are more stable than those at position 913.
The first and second Gly?Ser mutations destabilize both
the folded and unfolded states but destabilization of the
folded state is greater. This destabilizing trend is the same for
both peptide systems. The destabilizing effect is larger for the
1st Gly mutation (by 9.7 kcal/mol on chain A and 6.7 kcal/
mol on chain C) than the 2nd mutation (by 0.1 kcal/mol on
chain C and 3.1 kcal/mol on chain A) for the mutant con-
taining a Ser at position 913. The destabilizing effect is
smaller for the 1st Gly mutation (by 2.2 kcal/mol on chain A
and 4.5 kcal/mol on chain C) than the 2nd mutation (by 2.4
kcal/mol on chain C and 0.1 kcal/mol on chain A) for the
mutant containing a Ser at position 901. Contributions to
the free energy change difference from electrostatic terms
(DDGElec) stabilize the mutants containing one or two Ser
residues relative to the wild type for the Gly?Ser mutations
at both positions. However, van der Waals terms (DDGvdW)
destabilize the mutants having one or two Ser residues with
respect to the wild type at both mutation sites. For the folded
and unfolded states of both collagen model peptides almost
all of the covalent and noncovalent contributions disfavor
the mutants containing one or two Ser residues relative to
FIGURE 3 Thermodynamic cycle used to calculate free energy
differences of the first and second Gly?Ser mutations at the folded
and unfolded states. The calculation (DGunfol
mut) at the unfolded
state was carried out once and used for each Gly mutation. a01(I):
Gly at the central position is replaced by Ser. Collagenfol
mu(I):
a01(I)a1(I)a2(I) (mutant containing a Ser residue on Chain A).
Collagenfol
mu(I0): a1(I)a01(I)a2(I) (mutant containing a Ser residue
on Chain C). Collagenfol
mu(II): a01(I)2a2(I) (mutant containing two
Ser residues). Collagenunfol
wt: Ac-PVGPV-NH2 at 901; Ac-PQGPR-
NH2 at 913. Collagenunfol
mu: Ac-PVSPV-NH2 at 901; Ac-PQSPR-
NH2 at 913.
Table I Contributions to Free Energy Change Differences
(DDG) for 1st and 2nd Gly?Ser Mutations at Positions 901 and
913 in the Collagen-like Peptides (kcal/mol)
Chain A Chain C A:C C:A
At position 901
Mutation 1st 2nd
DDGTotal 2.2 4.5 2.4 0.1
DDGElec 23.6 22.5 22.4 23.5
DDGvdW 5.2 6.4 5.2 4.0
DDGCov 20.3 20.5 20.3 20.4
Folded state
DGTotal
Fold 11.5 13.8 11.7 9.4
DGElec
Fold 20.1 1.0 0.2 20.9
DGvdW
Fold 5.0 6.2 5.0 3.8
DGCov












DDGTotal 9.7 6.7 0.1 3.1
DDGElec 21.8 22.0 22.0 21.8
DDGvdW 8.6 8.0 2.1 3.0
DDGCov 2.9 0.9 0.0 2.0
Folded state
DGTotal
Fold 19.6 16.6 10.0 13.0
DGElec
Fold 0.6 0.4 0.4 0.6
DGvdW
Fold 9.4 8.5 2.9 3.8
DGCov










A:C–the first mutation on chain A and the second mutation on chain C.
C:A–the first mutation on chain C and the second mutation on chain A.
Average values of forward and reverse calculations from three independ-
ent simulations for each mutation are reported.
Statistical errors of DDGTotal for 1st and 2nd Gly mutations at positions
901 and 913 are 0.5 and 0.4 kcal/mol, respectively. Statistical errors of
DDGElec for 1st and 2nd mutations at positions 901 and 913 are 0.5 and 0.2
kcal/mol, respectively. The errors of DDGCov for the corresponding positions
are 0.5 and 0.3 kcal/mol, respectively. The errors of DDGvdW for both posi-
tions are 0.6 kcal/mol.
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the wild type; however, all the Gly?Ser mutations disfavor
the systems at the folded states more than those at the
unfolded states. The relative free energy change differences of
heterozygous and homozygous Ser-containing mutants are
greater for the peptide system at lethal mutation site than
that at the nonlethal mutation site. The significant free
energy differences between the systems are mainly from the
1st mutations rather than the 2nd mutations.
The root-mean-square deviations (RMSDs) of all the sol-
vated backbone atoms (chain A: residue 11–19, chain B: resi-
due 13–21, chain C: residue 12–20) of the average structures
with respect to minimized initial structures were estimated
from three independent MD trajectories (k 5 0.9). The
RMSDs for the Gly?Ser mutations at positions 901 and 913
are in the range of 0.6–0.8 Å and 0.9–1.4 Å, respectively. The
RMSDs of the backbone atoms in each chain from the 1st
Gly mutations at position 901 are 0.4–0.7 Å for chain A, 0.5–
0.8 Å for chain B, and 0.6–1.0 Å for chain C; however, the
corresponding RMSDs from the 1st mutations at position
913 are 1.0–1.2 Å for chain A, 0.9–1.7 Å for chain B, and 0.9–
1.1 Å for chain C (see Figure 4). The RMSD of the backbone
atoms of the system at the mutation position 901 are smaller
than those of the system at the position 913.
Average dihedral angles (u, w) of residues near the muta-
tion site, residues 14, 15, and 16 of the model peptide (resi-
due 900, 901, and 902 in human collagen sequence), from
the trajectories with k5 0.9 for the first and second Gly?Ser
mutations exhibit u from 2508 to 2718 and w from 1328 to
1618, respectively. These dihedral angles (u, w) are similar to
the typical (u, w) angles found in polyproline II, (2788,
1498).30 The average dihedral angles (u, w) of the corre-
sponding residues from the trajectories with k 5 0.9 for the
first and second Gly?Ser mutations at position 913 u are
from 2558 to 2808 and w from 1348 to 1638. However, the
w values of the residue at positions 14 and 15 (residues 912
and 913 in human collagen sequence) for the 1st mutation
on chain A are 1198 and 21598, respectively. These values are
significantly deviated from the typical dihedral angle values
of polyproline II. The larger RMSDs of the backbone atoms
for 1st Gly mutations at position 913 and the significant
deviation of dihedral w angles of the 14th and 15th residues
from the typical dihedral angles of polyproline II are caused
by strong steric interactions between neighboring side chains
at the mutation site.
DISCUSSION
The common single point OI mutations in Type I collagen
show various phenotypes ranging from mild to prenatally
lethal ones. The single base substitutions lead to mutation of
Gly by another amino acid, breaking the repeating sequence
pattern of Gly-X-Y in the collagen triple helix. Statistical
analysis of clinical phenotypes of OI has demonstrated that
all Gly?Asp mutations reported in the a1(I) chain are lethal;
Gly?Arg, Val and Glu are lethal unless the mutation sites
are near the N-terminus; Gly?Ala, Cys and Ser are lethal or
nonlethal all along the chains.12 The gradient model suggests
that mutations near the C-terminus are more severe than
those near the N-terminus. Although this model supports
the correlation for Gly?Arg and Val mutations in the a1(I)
chain, the regional model emphasizes that local amino acid
sequence environment and stability or binding sites are im-
portant in determining the severity of OI. This model has
been proposed for the most common Gly?Cys and Ser
mutations.31,32
To investigate the effect of amino acid sequence environ-
ment on the severity of OI, an amino acid sequence of
human collagen from residue 887 to residue 928 was
employed. Two collagen model peptides for Gly?Ser muta-
tions were prepared: (1) a mild phenotype at position 901
and (2) a lethal phenotype at position 913. Our simulation
results show that free energy change differences of the pep-
tide systems for 1st Gly?Ser mutations at positions 901 and
913 are on average 3.4 and 8.2 kcal/mol, respectively, and
that free energy differences of the mutants containing two
Ser residues relative to the wild types are 4.6 and 9.8 kcal/
mol at the corresponding positions (see Figure 5). The free
energy change differences of heterozygous and homozygous
mutants at position 901 are smaller than those at position
913 by 5 kcal/mol. The severe clinical phenotype of the
mutant at position 913 is mainly caused by the 1st mutation.
In the mutation at position 913 on chain A, the thermal sta-
bility of the heterozygous mutant relative to the wild type is
similar to that of homozygous mutant.
The free energy change differences of first and second
Gly?Ser mutations at position 901 on chain A are 2.2 and
2.4 kcal/mol, respectively. The relative destabilizing effects by
the 1st and 2nd Gly mutations are almost identical. This
FIGURE 4 RMS deviations of backbone atoms of average struc-
tures (red) from the trajectories (k 5 0.9) for the 1st Gly?Ser
mutation (A) at position 901 in chain A and (B) at position 913 in
chain A with respect to each corresponding minimized initial struc-
ture (blue).
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degree of destabilization caused by 1st and 2nd Gly muta-
tions is different from that of previous simulations on the
fully and partially solvated helical triple peptide systems
composed of repeating units of (Gly-Pro-Hyp).26,16 With this
homotrimeric peptide model, the 1st mutated residues cause
larger destabilizations of all the helical triple collagen-like
peptides than the 2nd mutated residues. The heterotrimeric
collagen-like peptide model used in this study is more struc-
turally flexible and is composed of more varied residue
sequences than the homotrimeric model. The different
degree of destabilizing effects by the 1st and 2nd mutations
with respect to the wild type might be caused by a different
type of heterotrimeric and homotrimeric triple helical
model, structural robustness of the chains or amino acid
sequence in the triple-helical peptides.
The different chemical and geometrical environments of
the nonpolar or polar side chains of the residues near the
mutation sites affect the nonlethal or lethal phenotypes of
the Gly?Ser mutations. The polar and bulky side chains of
the Gln and Arg residues at positions 14 and 17 on chain C
are placed closely across the mutating residue at position 15
on chain A (position site in the model peptides) for the lethal
mutation. By way of contrast, the nonpolar Val residues are
placed at the corresponding positions on chain C for nonle-
thal mutation (see Figure 6). During the Gly?Ser mutation
in these peptide systems, the mutated residue could interact
with polar or bulky side chains of the residues more unfavor-
ably than with side chains of small or nonpolar residues.
These unfavorable van der Waals interactions between side
chain of the mutating residue and the side chains of the
amino acids, such as Gln, Pro, and Arg, near the mutation
site more significantly decrease the stability of the lethal mu-
tant for the Gly?Ser mutation.
The RMSD of the backbone atoms of the average structures
for the 1st Gly mutation at position 913 is 1.4 6 0.1 Å (see
Figure 4), which is twice as large as that for the mutation at
position 901 (0.7 6 0.1 Å). The mutant containing a Ser at
position 913 is less stable than that at position 901 by 7.2 kcal/
mol. The dihedral angle deviation near the mutation site at
position 913 also seems to be related to unfavorable contribu-
tions to relative free energy change difference of the mutant
containing a Ser at position 913 relative to the wild type. The
more significant structural deviations estimated from RMSD
of the backbone atoms and dihedral angles near the mutation
sites are found in the 1st Gly mutation at position 913.
We previously calculated relative free energy change differ-
ences of collagen-like peptides between the wild type and
mutants containing Ser, Cys, Glu and Asp residues.16 The rel-
ative free energy changes for 1st mutations from Gly to Ser,
Cys, Glu and Asp were 3.8, 4.2, 5.6, and 8.8 kcal/mol, respec-
tively. The corresponding relative free energy change differ-
ences of mutants containing two mutated residues with
respect to the wild type were 5.1, 5.7, 8.5, and 14.2 kcal/mol,
respectively.16 The statistical analysis of OI mutations and
relative free energy change differences demonstrated that the
Gly?Ser and Cys mutations showed mild phenotypes and
Gly?Asp exhibited a severe case.12,16 In this study the rela-
FIGURE 5 Relative free energy change differences of the wild type
and mutants containing one or two Ser residues of the collagen-like
peptides. (Unit: kcal/mol). (a) at the nonlethal mutation site (at
position 901), (b) at the lethal mutation site (at position 913). WT:
Wild type, Mut(I) and Mut(I0): Mutant containing a Ser residue on
chains A and C, respectively, and Mut(II): Mutant containing two
Ser residues.
1st Mutation: WT?Mut(I) on chain A, WT?Mut(I0) on chain C
2nd Mutation: Mut(I)?Mut(II) on chain A, Mut(I0)?Mut(II) on
chain C.
DDGcalc ð1st mutation on chain AÞ ¼ DGfolmutðIÞDGunfolmut
DDGcalc ð1st mutation on chain CÞ ¼DGfolmutðI0ÞDGunfolmut
DDGcalc ð2nd mutation on chain AÞ ¼ DGfolmutðIIÞ  DGunfolmutðIÞ
DDGcalc ð2nd mutation on chain CÞ ¼ DGfolmutðII0 Þ  DGunfolmutðI0Þ
DDGcalc ð1st and 2nd mutationsÞ ¼ DGfolmutðIÞ þ DGfolmutðIIÞ
 2DGunfolmut
¼ DGfolmutðI0Þ þ DGfolmutðII0Þ
 2DGunfolmut
At the folded state : DGfol
mutðIÞ þ DGfolmutðIIÞ ¼ DGfolmutðI0Þ
þ DGfolmutðII0Þ ð1Þ
DDGexpt ¼ DGuwt  DGumut
DðDGÞ ¼ DGfolmutðIÞ þ DGfolmutðIIÞ  2DGunfolmut
¼ DGfolmutðI0Þ þ DGfolmutðII0 Þ  2DGunfolmut








DU ¼ U1  U0
ð3Þ
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tive free energy change differences of the first and second
Gly?Ser mutations at positions 901 and 913 correlate with
mild and severe clinical phenotypes, respectively.17,18 The
mutants containing two Ser residues are less stable than their
wild types by 4.6 kcal/mol at a nonlethal position and
9.8 kcal/mol at a lethal position (see Figure 5). The different
clinical phenotypes of these mutations at different sites
are consistent with the correlation of our calculated free
energy change difference of the mutants relative to the wild
type with the severity of OI from statistical analysis (see
Figure 7).16
Mooney et al. previously carried out free energy simula-
tions on a fully solvated collagen-like peptide for the mutation
Gly?Ala to estimate thermal stability of the mutant relative
to the wild type.26 The folded and unfolded peptide systems
were [Ac-(Gly-Pro-Hyp)10-NH2]3, and Ac-Pro-Hyp-Gly-
Pro-Hyp-NH2, respectively where the central Gly was mutated
to Ala. The simulation result was consistent with the experi-
mental value.20 We also carried out MD simulations on the
same collagen-like peptide systems for the mutation
Gly?Ala, but in a partially solvated water sphere using the
SBMDmethod.16 The simulation results with the partially sol-
vated peptide models were consistent with the fully solvated
systems, which validated the partially solvated collagen pep-
tide model.16 In this article we employ the same simulation
method with the partially solvated model to expedite the free
energy simulations on our triple helical peptides. To achieve a
more accurate free energy changes and realistic pictures of the
peptide systems, we would better simulate the peptide systems
in more extensive solvent systems without truncation or
FIGURE 6 The minimized collagen peptide models (k 5 0) of (a) nonlethal and (b) lethal
mutation sites. (Color: Red, blue, white and light blue indicate oxygen, nitrogen, hydrogen and
carbon, respectively.) A, B and C indicate the chains of the model peptides. Three Gly’s at posi-
tion 15 in both peptide models are shown using CPK model and the residues at positions 14, 16,
and 17 are shown with VDWmodel. The rest of the residues are shown with lines. The arrows in
(b) indicate the unfavorable interactions between the side chains of the mutating residue on
chain A and the Gln and Arg on chain C.
FIGURE 7 Correlations of the free energy change differences
(kcal/mol) for the Gly?Ser mutations at positions 901 and 913
with the severity of OI. For comparison, previously estimated free
energy change differences of Gly?Xaa mutations (Xaa: Ser, Cys,
Glu and Asp) with the severity of OI (Lee et al.). A mutant contain-
ing two Cys residues is a reduced form. (Color: light grey, first
Gly?Xaa mutations; black, average values of two second Gly?Xaa
mutations; and grey, first and second Gly?Ser mutations at posi-
tions 901 and 913).
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constraints. Longer simulations would improve statistical
sampling of the system. High temperature simulation could
improve the model for unfolded structure of the peptide
model systems.33
CONCLUSIONS
We carried out MD simulations of collagen-like peptides for
the Gly?Ser mutations to investigate the effect of amino
acid sequence environment on the severity of OI. The pep-
tide sequences of the model peptides are from human colla-
gen containing a mutation site at positions 901 and 913 for
the Gly?Ser mutation, which show nonlethal and lethal
phenotypes, respectively.17,18 The Ser-containing nonlethal
heterozygous and homozygous mutants are predicted to be
more stable than the corresponding lethal mutants by 4.8
and 5.2 kcal/mol, respectively. The different clinical severity
of OI for Gly?Ser mutations is consistent with the relative
free energy differences caused by amino acid sequence envi-
ronment adjacent to a mutation site. The polar and bulkier
amino acids near the mutation site provide more destabiliz-
ing effect on the lethal mutant for the Gly?Ser mutations.
The free energy simulation results for the Gly?Ser mutation
of collagen-like peptide show that the lethality of the clinical
phenotype of OI is in agreement with the severity of OI
obtained from statistical analysis. The free energy change dif-
ferences from the Gly?Ser mutations also agree with the
trend in the severity of OI obtained on the collagen model
system, [(Pro-Hyp-Gly)9]3 for the Gly?Xaa mutations (Xaa:
Ser, Cys, Glu, Asp).16 Our MD simulation results indicate
that the simulation method to calculate the relative free
energy change differences of the homozygous or heterozy-
gous mutants relative to the wild type with various clinical
phenotypes can be used to estimate the degree of severity of
OI and other collagen-related diseases.
The authors thank Dr. Charles L. Brooks III for allowing us to use his
dual Quad-core Intel Xeon cluster and for commenting on this
manuscript. The figures were prepared by using the VMD program.34
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